APPOINTMENTS (602) 482-2116

PHOENIX & GLENDALE
MENUMENU
  • Home
  • Doctors
    • Jeffrey Gitt, DO
    • Leslie Zuniga, M.D
    • Evelyn Sikora, Psy.D., NPs
    • Barry A. Hendin MD
    • Lori Travis MD
  • Specialties
    • Infusion Center
    • Neurology
    • Neuropsychology
  • Referring Physicians
  • For Patients
  • FAQ
  • Blog
  • Contact
  • Patient Portal

COVID 19 Vaccine Considerations for Healthcare Providers

by drgitt | Apr 2, 2021 | Uncategorized

https://www.nationalmssociety.org/For-Professionals/Clinical-Care/COVID-19/COVID-19-Vaccine

This is the National MS Society statement on vaccines for patients with MS taking disease modifying therapies.

Recent Posts

  • COVID 19 Vaccine Guidance for People living with MS
  • COVID 19 Vaccine Considerations for Healthcare Providers
  • Timing MS Medications with COVID-19 Vaccines
  • Eli Lilly COVID drug combo cuts risk of hospitalizations, deaths by nearly 90%
  • Molnupiravir-A new therapeutic for treatment of COVID-19

Archives

  • April 2021
  • March 2021
  • February 2021
  • December 2020
  • October 2020
  • August 2020
  • June 2020
  • May 2020
  • August 2019
  • July 2017
  • June 2017
  • April 2017
  • August 2016
  • July 2016
  • June 2016
  • May 2016
  • October 2015
  • August 2015
  • June 2015
  • May 2015
  • April 2015
  • February 2015
  • January 2015
  • December 2014
  • November 2014
  • October 2014
  • August 2014
  • June 2014
  • May 2014
  • April 2014
  • March 2014

© Center for Neurology and Spine. All Rights Reserved.